strong growth across rtg mitg segment
maintain hold rate upgrad tp
deriv tp base forward price-to-earnings multipl
adjust ep provid upsid
potenti estim top-
line revenu grow
report world-wide revenu
increas report organ basi
adjust neg impact foreign currenc
contribut compani acquisit titan
spine report spine divis restor
report net incom dilut earn per
share ep respect non-gaap
net incom non-gaap dilut ep
respect increas respect
 revenu increas
repres compani revenu non-u develop
market revenu repres compani
revenu increas report emerg market
revenu repres compani revenu
increas report
cvg quarter revenu decreas report
increas constant currenc basi cvg revenu
perform driven high-singl digit growth csh
off-set flat result apv low-singl digit declin crhf
constant currenc basi
compani name plc tickermdtstock ratingholdunchangedindustri viewoverweightpositivepric jan week week volum volum ep margin margin ttm per share growth profit ttm ttm incom ttm earn growth plc januari
incom statement
non-
per share item
product perform develop
valuat consensu perform
mitg quarter revenu increas
report constant currenc basi mitg
revenu perform driven balanc growth
across divis mid-singl digit constant
currenc growth si
rtg quarter revenu increas report
well organ basi adjust
neg impact foreign currenc posit
contribut compani acquisit titan spine
rtg revenu perform driven low-doubl digit
growth brain therapi mid-singl digit growth
specialti therapi spine low-singl digit growth
pain therapi organ basi
diabet group quarter revenu increas
report diabet group revenu perform led
intern market grew report
driven on-going launch minim hybrid
expect growth rate acceler
grow faster first launch sever new
product expect top-line momentum
acceler compani get increas benefit
product launch well product slate
launch next fiscal year
stock price histori date high obsolet date obsolet move move share statist averag volum averag volum share held held share short short share short prior dividend split forward annual dividend forward annual dividend trail annual dividend trail annual dividend year averag dividend pay-out dividend date jan ex-dividend date dec last split factor new per last split date sep inform medtron plc januari
incom statement
non-
per share item
product perform develop
valuat consensu perform
non- reconcili refer page
incom statement item total y/i revenu growth gross gross gener sg amort oper total oper oper oper margin incom incom provis incom net incom continu net incom avail common net margin per y/i ep growth averag share estim annual actual annual actual quarterli plc januari
equival short term invest trade asset secur total st invest receiv account receiv receiv total receiv current asset inventori prepaid expens defer tax asset current current asset total current asset long-term asset gross properti plant equip accumul depreci net properti plant equip long-term invest goodwil intang defer tax asset long-term asset total asset current liabil account payabl accru expens short-term borrow current portion lt debt current incom tax payabl unearn revenu current current liabil total current liabil long-term liabil long-term debt unearn revenu non-curr pension post-retir benefit def tax liabil non-curr capit leas non-curr liabil total liabil common equiti common stock addit paid capit retain earn comprehens incom total common equiti stockhold equiti minor interest total equiti liabil equiti total liabil equiti balanc sheet itemsactu annual actual quarterli plc januari
provid oper activ compar
decreas net cash provid driven increas cash paid employe increas
cash paid incom tax due tax payment associ inter-company sale intellectu
properti lower transact tax payment compar
use invest activ compar cash provid
increas net cash use attribut decreas net proce
purchas sale invest increas cash paid acquisit
increas cash paid addit properti plant equip million six month
end octob compar correspond period prior fiscal year
use financ activ compar
decreas primarili attribut decreas net cash use share repurchas billion
also impact issuanc billion euro-denomin senior note off-set tender
billion senior note billion total consider
net incom oper activ depreci amort amort goodwil intang depreci amort total loss sale asset loss sale invest asset write-down restruc cost stock-bas compens oper activ chang account receiv chang inventori chang account payabl chang net oper asset oper invest activ capit expenditur acquisit divestitur sale purchas intang asset invest market equiti securt invest activ invest financ activ short term debt issu long-term debt issu total debt issu short term debt repaid long-term debt repaid total debt repaid issuanc common stock repurchas common stock common prefer stock dividend paid financ activ financ chang equival foreign exchang rate adjust net chang total net revenu
increas
compar
cog increas
compar
plc deliv growth total revenu solid perform
emerg market increas segment perform mitg rtg cvg
net revenu increas compar
revenu increas constant currenc basi
adjust neg impact foreign currenc growth
revenu due out-performance mitg rtg diabet segment
total revenu increas compar
total non-u develop market revenu increas
compar total emerg
market revenu increas compar
cog increas compar cog
sale compar
increas cost product sold revenu driven increas
restructur associ cost increas duti driven part increas
china tariff inbound product addit expens incur overcom
steril shortag minim invas therapi group cog includ
restructur associ cost compar
 expens compar
expens sale compar
sg expens compar
sg expens sale compar
decreas benefit enterpris excel program
amort expens compar
restructur charg compar
partial off-set accrual adjust relat certain
employe identifi termin find posit within
restructur charg includ recogn within net
restructur charg consolid statement incom primarili
compris employe termin benefit
net non oper
incom
compar
also includ cost incur direct result restructur program
salari employe support program consult expens
includ recogn within cog recogn within sg
expens consolid statement incom
certain litig charg litig
charg net oper incom
compar oper expens
chang net oper incom expens primarili attribut
re-measur hedg program combin result
gain compar loss
addit charg respect exit busi
net non oper incom compar
chang net non-oper incom primarili
attribut gain loss minor invest portfolio
gain compar loss
interest expens decreas compar
decreas primarili due decreas weighted-averag
interest rate outstand debt oblig compar
driven compani debt issuanc tender transact
incom tax compar
provis tax compar
effect tax rate compar
non-gaap nomin tax rate compar
rate
compar
increas effect tax rate compar due
impact certain tax adjust
gaap ep
non-gaap ep
net incom increas compar
non-gaap net incom
gaap ep increas compar non-
gaap ep
net revenu increas
compar
due strong
perform mitg
rtg
net revenu increas compar
due strong perform mitg rtg cog
increas compar
research develop expens sell gener
administr expens compar
amort intang asset expens
compar
restructur charg compar
certain litig charg compar
oper expens decreas compar
oper expens associ exit busi charg
compar
non-oper incom decreas compar
chang non-oper incom primarili
due loss minor invest compar gain
minor invest
interest expens increas compar
increas primarili due driven million charg
recogn connect tender earli redempt billion
senior note partial off-set decreas weighted-averag interest
rate outstand debt oblig due aforement debt issuanc
tender transact
incom tax compar
provis tax compar
effect tax rate compar
non-gaap nomin tax rate compar
net incom increas compar
non-gaap net incom
gaap ep increas compar
non-gaap ep
interest expens
compar
gaap ep increas
compar
oper four segment cardiac vascular group cvg
diabet group
cvg segment contribut revenu mitg segment contribut
revenu rtg segment contribut revenu diabet segment
contribut revenu
revenu mitg
revenu rtg segment
contribut
revenu diabet
revenu
cardiac vascular group cvg cardiac vascular group segment
includ cardiac rhythm heart failur crhf coronari structur heart
csh aortic peripher vascular apv crhf contribut
segment revenu apv contribut segment revenu csh
contribut segment revenu
cardiac vascular group cvg
cardiac vascular group sale decreas
compar decreas due flat
perform aortic peripher venou low-singl digit perform
cardiac rhythm heart failur increas seem term
cvg revenu decreas
compar cvg revenu non-u
develop market decreas compar
cvg revenu emerg market increas
compar
cardiac rhythm heart failur sale decreas
compar cardiac rhythm heart
failur revenu decreas driven low-singl digit growth
arrhythmia manag low-doubl digit growth af solut
compar
compar
coronari structur heart revenu increas
compar increas driven
growth sale transcathet aortic valv reflect expans
low risk patient popul transcathet aortic valv growth off-set
mid-singl digit declin drug-elut stent
compar
cardiac vascular group cvg
aortic peripher venou revenu decreas
compar growth aortic
venou offset declin peripher aortic revenu growth
driven growth thorac aortic stent graft reflect strong demand
valiant navion
venou revenu growth driven off-set high-singl digit
constant currenc declin peripher driven low-thirti constant
currenc declin drug-coat balloon
group segment includ surgic innov si respiratori
gastrointestin renal divis si divis contribut
revenu divis contribut revenu
revenu increas
minim invas therapi group revenu increas
compar mitg revenu
perform driven balanc growth across divis mid-
singl digit constant currenc growth si
mitg revenu increas
compar mitg revenu non-u
develop market increas compar
mitg revenu emerg market increas
compar
surgic innov revenu increas
compar increas driven continu
growth advanc advanc stapl advanc
show continu growth sale ligasur vessel seal
instrument includ ligasur exact dissector advanc stapl
grew due strong demand tri-stapl endo stapl specialti
reload eea circular stapler tri-stapl technolog
respiratori gastrointestin renal revenu increas
compar increas
driven strength respiratori patient monitor gi
solut respiratori patient monitor grew due strong sale
nellcor puls oximetri increas adopt advanc paramet
bennett ventil mcgrath video laryngoscop gi
solut grew due solid growth bravo calibration-fre reflux test
system endoflip imag system pillcam capsul endoscopi
revenu increas
compar
revenu increas
compar
restor therapi group revenu increas
compar increas revenu
driven brain therapi specialti therapi divis posit
contribut compani acquisit titan spine currenc
unfavor impact revenu
rtg revenu increas
compar rtg revenu non-u develop
market increas compar
revenu emerg market increas
compar
spine revenu increas compar
increas revenu due compani sale
enabl technolog use spine surgeri includ robot navig
imag power surgic instrument recogn brain
spine also benefit pull-through core spine implant
use mazor robot case well strong sale infus bone graft
grew low-doubl digit organ basi
brain therapi revenu increas
compar increas driven strong
growth neurovascular neurosurgeri revenu growth
neurovascular driven constant currenc growth hemorrhag
stroke growth ischem stroke growth hemorrhag stroke
busi due flow divers product particularli pipelin
compar
compar
also saw strong adopt recent launch solitair stent
retriev product well riptid aspir system react
cathet neurosurgeri revenu growth driven continu strong
demand stealthstat surgic navig system o-arm imag
system mazor robot guidanc system
specialti therapi revenu increas
compar increas revenu driven
capit equip sale stealthstat ent surgic navig system
intraop nim nerv monitor system ent along sale
interstim ii neurostimul pelvic
pain therapi revenu remain flat valu show
compar decreas revenu
due intervent pain growth partial off-set declin pain
stimul base continu success kyphon vertebroplasti
osteocool rf spinal tumor ablat system
increas
compar
revenu increas
compar
diabet group revenu increas
compar increas primarili attribut
growth intern market result strong consum demand
minim addit continu adopt guardian connect
smart cgm system contribut revenu growth period currenc
unfavor impact revenu
diabet group revenu decreas
compar revenu non-u develop
market increas compar
revenu emerg market increas
compar
revenu increas
compar
total revenu
expect
organ basi
neg effect
total revenu expect increas organ basi
neg effect
non-gaap ep expect rang
estim neg impact due current rate foreign
revenu growth cvg expect grow mitg expect
grow rtg expect grow diabet expect
show low-singl digit organ growth due competit pressur
wait approv new product
revenu grew
growth
mitg rtg diabet
segment growth
revenu increas organ basi
increas perform mitg rtg diabet segment emerg
market show solid growth quarter wherea market non-
 market low growth ep increas non- ep
quarter
cog increas due increas restructur
associ cost increas duti driven part increas china tariff
medtron upcom product launch mitg includ ligasur vessel seal
instrument nano-co ligasur exact dissector l-hook
laparoscop sealer/divid valleylab energi platform
growth basi point ahead expect strong sale
spine brain therapi off-set slower growth pain therapi
surgic synergi strategi spine surgeri combin enabl
capit equip brain therapi divis implant spine
divis except sustain impact rtg growth
cardiac vascular group revenu decreas
due unfavor impact currenc revenu declin net
sale cardiac rhythm heart failur partial off-set increas net sale
coronari structur heart
minim invas therapi group revenu increas
partial off-set unfavor impact currenc
revenu
expect growth rate acceler grow faster
first launch sever new product expect top-line
momentum acceler compani get increas benefit
product launch well product slate launch next fiscal year
non- reconcili
non- reconcili
non- reconcili
incom statement
non-
per share item
product perform develop
valuat consensu perform
gross margin decreas ttm basi compar
oper margin increas ttm basi compar
net margin decreas ttm basi compar
ep growth ttm basi compar
ratio revenu margin margin inc margin rate margin turnov averag asset leverag averag equiti year averag averag averag year averag averag averag year averag averag averag marginsprofitabilityrevenu growth oper incom growthep growth plc januari
mrqgross mrqoper mrqnet mrqcog mrqsg mrqr sale medtron plc januari
invest flow
sale
mrqyoy growth revenu growthoper incom growthep mrq ratio growth yoy oper growth yoy free growth mrqcapex salescap ex salesfre mrqfinanci mrqreturn mrqreturn asset medtron plc januari
per share item ratio
fiscal per ebitda per ebit per earn per share ep ep free flow per dividend per book valu per tangibl book per month end stock month end stock equiti return asset return invest capit return capit joel greenblatt debt gross margin oper margin net margin total equiti total lt debt total asset dividend pay-out day sale day account day convers inventori cog inventori tax rate net incom net incom discontinued- net net margin prefer dividends- annual itemsquarterli item medtron plc januari
balanc sheet item
outstand equival market debt common stock- prefer stock- purchas properti plant sale properti plant equipment- purchas sale business- purchas sale issuanc repurchas net issuanc prefer stock- net issuanc net chang capit free plc januari
current price-to-earnings price-to-earnings price-to-earnings trade
past averag price-to-earnings expect
forward price-to-earnings
incom statement
non-
per share item
product perform develop
valuat consensu perform
breakdown share held share held float held institut hold institut holdersholdersharesd report outvaluevanguard group inc manag compani street financi servic asset manag row associ capit manag trust corpor mutual fund holdersholdersharesd report outvaluevanguard total stock market etf seri trust i-mf valu institut fund-institut fund fund specialized-dividend growth fund specialized-dividend appreci plc januari
develop file suit axon ip infringementnov inc file lawsuit inc axon alleg infring patent relat minim invas sacral neuromodul lead placement procedur implant recharg technolog suit file unit state district court central district california seek injunct relief damag infring new studi show promis treat patient world smallest pacemakernov plc announc result marvel micra atrial track use ventricular acceleromet studi show investig set algorithm micra transcathet pace tp significantli improv synchroni cardiac function patient impair electr conduct chamber heart call atrioventricular av block result marvel studi present nov featur scienc session american heart associ aha scientif session publish today jacc clinic electrophysiolog christiana collabor improv patient outcom reduc delawaredec plc christiana announc collabor design improv outcom christiana patient delawar surround region five-year agreement focu develop deploy value-bas healthcar initi help christiana appli right medic technolog therapi patient may benefit share financi account christiana improv patient outcom reduc cost care expand surgic synergi sm fda clearanc stealth autoguid cranial plc announc food drug administr fda recent clear stealth autoguid system first cranial robot platform integr enabl technolog portfolio creat end-to-end procedur solut stealth autoguid platform robot guidanc system intend spatial posit orient instrument holder tool guid use neurosurg procedur plc januari
incom statement
non-
per share item
product perform develop
valuat consensu perform
consensu view analyst trend stock
forecast compar
forward price-to-earnings
compar
mdt avgfive-year growth forecast usdgrowth high day day day estim comparisonmdtindustri avg avgprice/earn yield plc januari
consensu view analyst trend stock
averag earn estim
current qtr
next qtr
sale growth estim current
yr next yr
averag revenu estim
current qtr
estimatescurr analyst estimatethi estim estimatepast ep growthprice/earningsobsoleteobsoleteobsoleteobsoletepeg ratioobsoleteobsoleteobsoleteobsoleteconsensu ep day day day day ep last last daysn/an/an/an/adown last daysobsoleteobsoleteobsoleteobsoletedown last dayscurr surprisescurr growth rate medtron plc januari
incom statement
non-
per share item
product perform develop
valuat consensu perform
stock price volatil period gave return quarter
averag volum stock
stock price volatil till april show upward trend current trade
stock gave return past rang stock
stock price show upward trend past year
stock gave return past
deliv strong perform quarter growth revenu
contribut compani acquisit titan spine recommend hold rate stock
tp
crispidea financi inform servic firm focus provid equiti research portfolio manag
person wealth manag brokerag servic inform servic side provid commun
consult research servic host ofclient
crispidea track limit number compani sector strive provid qualiti insight straight
forward analysi object creat long-term wealth moder low risk crispidea leverag
larg number in-hous extern expert oper within industri strong financi oper
strateg background
detail visit www crispidea com orcontact
